Admitted local publications that cite Prospective performance of the IWG-2023 criteria and IPSS-M in a phase 2 trial of guadecitabine for higher-risk MDS or CMML.
No admitted local citation edges point to this work yet.
Cited by — Prospective performance of the IWG-2023 criteria and IPSS-M in a phase 2 trial of guadecitabine for higher-risk MDS or CMML | ResearchHub - ResearchHub
